schedules tabstyle

Live poling to influence OncoDNA founder and a high level profile of delegates, countries represented and products used at User Group 2026

OncoDNA is delighted that Gareth will ‘Chair’ User Group 2026
Gareth works at the South East Genomic Laboratory Hub as the Scientific Director and is also a Clinical Scientist (England, UK) with a background in translational research, education, and clinical implementation of genomic technology within the clinical, academic, and private sectors. Gareth led a strategic review of solid tumour testing undertaking a comparison of TSO500 with OncoDEEP. This led to his laboratory adopting OncoDEEP in 2023 as its assay of choice for all solid tissue testing in oncology. Gareth love for genomics is clear in his pursuit of encouraging research in his teams, seeking out innovative products and overseeing adoption of innovation within his own organisation ensuring that the South East Genomic Laboratory Hub continues to be a leader in genomic testing.

Everyone is talking about liquid, what products are available for oncologists? Why is liquid so interesting and what are the different applications in cancer? Limitations exist for tissue as well as liquid and it remains the case that tissue biopsy is the gold standard for cancer diagnostics
The choice between liquid and tissue is not a simple either/or decision
How to choose the right test based on the distinct, integrated roles liquid and tissue plays throughout a patient’s cancer journey

A summary of Day One. Learn how to benefit from the complimentary tour or consider how to take time to check into local hotels

All too often we travel to business meetings and never see the location. Take time to enjoy Valencia via this complimentary tour organised especially for OncoDNA customers old and new!

Meet other special guests and enjoy the inaugural Customer Awards - who knows if you have chosen to be a presenter the audience may vote for you. If you are at User Group to learn from other customers you will be enlightened by the innovation and collaboration evident amongst our own teams and that of our customers.

Spreading best practice when using OncoDNA's products. How do we use the awards winners experience to influence service delivery when we return to our own laboratories?

Report generation at OncoDNA using the OncoKDM platform is a clinical decision support process that converts raw genomic data into actionable oncology insight - learn more about how this works in practice and how to optimise reporting using OncoKDM in your own organisation

Using actual examples from OncoDNA's customers experience examine how best to deal with Challenging Next-Generation Sequencing (NGS) samples which can be typically low in quantity, highly degraded, or contain inhibitors, such as from Formalin-Fixed Paraffin-Embedded (FFPE) tissues, ancient DNA, low cell numbers, circulating cell-free DNA, or complex mixtures. These issues lead to DNA damage (breaks, adducts) and low complexity, requiring careful preparation to overcome challenges like PCR bias, low library yields, uneven coverage, and high duplicate reads, which can hinder reliable results.

A summary of what to expect from the OncoDNA Product Roadmap. We know that consistency builds trust, transparency enables innovation, clear ownership is paramount, human interaction is better than support ticket ping pong and the power of being a learning organisation means we are successful but importantly our customers are empowered to use our products successfully. We really believe that Genomics is easier when we work together

OncoDNA is committed that every customer attending User Group 2026 will leave with a concise summary of crucial outcomes: decisions made, key discussion points, and specific actions. Learn where User Group 2027 is to be located and how to get involved. See you in 2027!